ACvac 1
Alternative Names: ACvac1; COVID-19 peptide vaccine; COVID-19 vaccine - Axon Neuroscience; COVIDAXLatest Information Update: 12 Jan 2026
At a glance
- Originator Axon Neuroscience
- Class COVID-19 vaccines; Peptide vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued COVID 2019 infections
Most Recent Events
- 12 Jan 2026 Discontinued - Preclinical for COVID-2019 infections (Prevention) in Slovakia (Parenteral) (Axon Neuroscience pipeline; January 2026)
- 12 Jan 2026 Discontinued - Preclinical for COVID-2019 infections in Slovakia (Parenteral) (Axon Neuroscience pipeline; January 2026)
- 28 Oct 2024 No recent reports of development identified for preclinical development in COVID-2019-infections in Slovakia (Parenteral)